(2026). Comprehensive evaluation of an emergency monovalent SAT1 foot-and-mouth-disease vaccine: Antigen quality, product consistency, and protective efficacy. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Comprehensive Evaluation of an Emergency Monovalent SAT1 Foot-and-mouth-disease Vaccine: Antigen Quality, Product Consistency, and Protective Efficacy."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Comprehensive Evaluation of an Emergency Monovalent SAT1 Foot-and-mouth-disease Vaccine: Antigen Quality, Product Consistency, and Protective Efficacy."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.